Category Business

Bristol Myers Squibb Presents New Cardiovascular Findings at 2024 ACC Conference, Strengthening Evidence Base

Bristol Myers Squibb (NYSE: BMY) announced today the unveiling of data at the American College of Cardiology (ACC) Annual Scientific Session & Expo, scheduled for April 6-8, 2024, in Atlanta, Georgia. Roland Chen, MD, Senior Vice President and Head of…

Read MoreBristol Myers Squibb Presents New Cardiovascular Findings at 2024 ACC Conference, Strengthening Evidence Base

Awiqli®: European Authorities Recommend Approval for Weekly Basal Insulin Icodec in Diabetes Treatment

Novo Nordisk has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion, recommending the marketing authorization for Awiqli® (the branded name for once-weekly basal insulin icodec) for the treatment of…

Read MoreAwiqli®: European Authorities Recommend Approval for Weekly Basal Insulin Icodec in Diabetes Treatment

Legend Biotech Releases Debut Environmental, Social, and Governance (ESG) Report

Legend Biotech Corporation (NASDAQ: LEGN), a leading global figure in cell therapy, has unveiled its inaugural Environmental, Social & Governance (ESG) report. This comprehensive document provides an insight into Legend Biotech’s ESG initiatives, aligned with the Sustainable Accounting Standards Board…

Read MoreLegend Biotech Releases Debut Environmental, Social, and Governance (ESG) Report

Viatris Announces Closure of Global Research and Development Collaboration with Idorsia: Official Statement

Viatris Inc. recently concluded agreements for a comprehensive global research and development collaboration with Idorsia Ltd (SIX: IDIA), a transaction that was finalized on March 15, 2024. For detailed information regarding this significant transaction, please consult Viatris’ Annual Report on…

Read MoreViatris Announces Closure of Global Research and Development Collaboration with Idorsia: Official Statement

Optimizing Project Management for Pharmaceutical Manufacturing: A Roadmap to Effective Clinical Trials

Unlocking Project Management’s Role in CDMOs In the intricate web of pharmaceutical and biotech industries, Contract Development and Manufacturing Organizations (CDMOs) stand as pivotal partners, offering indispensable services like API synthesis, formulation, and packaging—essentials for drug manufacturing. Project management emerges…

Read MoreOptimizing Project Management for Pharmaceutical Manufacturing: A Roadmap to Effective Clinical Trials

Mirum Pharmaceuticals Scheduled to Attend Upcoming Investor Conferences

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading biopharmaceutical firm specializing in the discovery, acquisition, development, and distribution of innovative therapies for rare and orphan diseases, has revealed its participation in forthcoming investor conferences as follows: For webcast links and additional…

Read MoreMirum Pharmaceuticals Scheduled to Attend Upcoming Investor Conferences